$155.49
1.55% today
NYSE, Nov 21, 07:44 pm CET
ISIN
US4781601046
Symbol
JNJ

Johnson & Johnson Stock price

$153.11
-9.72 5.97% 1M
+1.84 1.22% 6M
-3.63 2.32% YTD
+3.20 2.13% 1Y
-6.59 4.13% 3Y
+17.17 12.63% 5Y
+44.93 41.53% 10Y
NYSE, Closing price Wed, Nov 20 2024
+0.11 0.07%
ISIN
US4781601046
Symbol
JNJ
Sector
Industry

Key metrics

Market capitalization $368.63b
Enterprise Value $384.08b
P/E (TTM) P/E ratio 25.31
EV/FCF (TTM) EV/FCF 18.51
EV/Sales (TTM) EV/Sales 4.38
P/S ratio (TTM) P/S ratio 4.20
P/B ratio (TTM) P/B ratio 5.25
Dividend yield 3.21%
Last dividend (FY24) $4.91
Revenue growth (TTM) Revenue growth -8.03%
Revenue (TTM) Revenue $87.69b
EBIT (operating result TTM) EBIT $21.57b
Free Cash Flow (TTM) Free Cash Flow $20.75b
Cash position $20.30b
EPS (TTM) EPS $6.05
P/E forward 22.94
P/S forward 4.15
EV/Sales forward 4.33
Short interest 0.75%
Show more

Create a Free Account to create an Johnson & Johnson alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Johnson & Johnson Stock Analysis

Analyst Opinions

24 Analysts have issued a Johnson & Johnson forecast:

12x Buy
50%
12x Hold
50%

Analyst Opinions

24 Analysts have issued a Johnson & Johnson forecast:

Buy
50%
Hold
50%

Financial data from Johnson & Johnson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
87,691 87,691
8% 8%
100%
- Direct Costs 27,474 27,474
10% 10%
31%
60,217 60,217
7% 7%
69%
- Selling and Administrative Expenses 14,940 14,940
14% 14%
17%
- Research and Development Expense 16,419 16,419
12% 12%
19%
28,858 28,858
12% 12%
33%
- Depreciation and Amortization 7,286 7,286
2% 2%
8%
EBIT (Operating Income) EBIT 21,572 21,572
15% 15%
25%
Net Profit 14,684 14,684
8% 8%
17%

In millions USD.

Don't miss a Thing! We will send you all news about Johnson & Johnson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Johnson & Johnson Stock News

Neutral
Forbes
about 6 hours ago
Given its better prospects, we believe that AbbVie stock (NYSE: ABBV) is currently a better pharmaceutical pick over Johnson & Johnson stock (NYSE: JNJ). Both AbbVie and J&J trade at 15x forward expected earnings.
Positive
Seeking Alpha
about 22 hours ago
AT&T, Altria Group, and Energy Transfer are top buys with dividends from $1K invested exceeding single share prices, meeting the dogcatcher ideal. Analysts forecast 15.47% to 28.33% net gains by November 2025 for top-ten F500IL dogs, with Energy Transfer as the standout “safer” choice. Eight F500IL stocks show negative free cash flow margins, making them unsafe buys; price drops or dividend inc...
Positive
Seeking Alpha
2 days ago
I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Both pay an attractive Dividend Yield [FWD] of 6.14% (Pfizer) and 6.58% (Verizon) and have a relatively low Valuation (P/E Non-GAAP [FWD] Ratio of 9.34 (Pfizer) and 8.80 (Verizon). To reduce the company-specific concentration risk of your investment portfolio, I suggest setting an allo...
More Johnson & Johnson News

Company Profile

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Head office United States
CEO Joaquin Duato
Employees 131,900
Founded 1887
Website www.jnj.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today